Carna Hospice Inc 348 East Olive Ave, Suite E, Burbank, CA, 91502 | |
(818) 561-4410 |
News Archive
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 2,500,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $500,000.00 to the Company.
Recently, several research groups emphasized how the pervasive screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may prove pivotal in determining infection seroprevalence in a given population defining previous exposure, screening health care workers, but also identifying highly reactive individuals that may act as donors for the therapeutic use of their convalescent serum.
A researcher in the United States has many of the pieces needed to cure a disease. Thousands of miles away, another scientist has uncovered some crucial information of his own - but thanks to the often secretive nature of research and development and the big-time dollars associated with major discoveries, they fail to connect.
As the results from the MINEX II report is released, Precise Biometrics emerges with the fastest standardized Match-on-Card and outstanding performance. Precise Biometrics is also the only biometric supplier who passed with 3 different card vendor submissions - a unique achievement in the industry.
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced its participation in the World Conference on Lung Cancer, to be held October 27-30, in Sydney, Australia.
› Verified 8 days ago
Name | Carna Hospice Inc |
---|---|
Location | 348 East Olive Ave, Suite E, Burbank, California |
Hospice ID | 751763 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 200 |
News Archive
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 2,500,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $500,000.00 to the Company.
Recently, several research groups emphasized how the pervasive screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may prove pivotal in determining infection seroprevalence in a given population defining previous exposure, screening health care workers, but also identifying highly reactive individuals that may act as donors for the therapeutic use of their convalescent serum.
A researcher in the United States has many of the pieces needed to cure a disease. Thousands of miles away, another scientist has uncovered some crucial information of his own - but thanks to the often secretive nature of research and development and the big-time dollars associated with major discoveries, they fail to connect.
As the results from the MINEX II report is released, Precise Biometrics emerges with the fastest standardized Match-on-Card and outstanding performance. Precise Biometrics is also the only biometric supplier who passed with 3 different card vendor submissions - a unique achievement in the industry.
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced its participation in the World Conference on Lung Cancer, to be held October 27-30, in Sydney, Australia.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 2,500,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $500,000.00 to the Company.
Recently, several research groups emphasized how the pervasive screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may prove pivotal in determining infection seroprevalence in a given population defining previous exposure, screening health care workers, but also identifying highly reactive individuals that may act as donors for the therapeutic use of their convalescent serum.
A researcher in the United States has many of the pieces needed to cure a disease. Thousands of miles away, another scientist has uncovered some crucial information of his own - but thanks to the often secretive nature of research and development and the big-time dollars associated with major discoveries, they fail to connect.
As the results from the MINEX II report is released, Precise Biometrics emerges with the fastest standardized Match-on-Card and outstanding performance. Precise Biometrics is also the only biometric supplier who passed with 3 different card vendor submissions - a unique achievement in the industry.
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced its participation in the World Conference on Lung Cancer, to be held October 27-30, in Sydney, Australia.
› Verified 8 days ago
Home Health Aides | 1 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 3 |
Other Personnel | 1 |
Total Employees | 9 |
---|
News Archive
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 2,500,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $500,000.00 to the Company.
Recently, several research groups emphasized how the pervasive screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may prove pivotal in determining infection seroprevalence in a given population defining previous exposure, screening health care workers, but also identifying highly reactive individuals that may act as donors for the therapeutic use of their convalescent serum.
A researcher in the United States has many of the pieces needed to cure a disease. Thousands of miles away, another scientist has uncovered some crucial information of his own - but thanks to the often secretive nature of research and development and the big-time dollars associated with major discoveries, they fail to connect.
As the results from the MINEX II report is released, Precise Biometrics emerges with the fastest standardized Match-on-Card and outstanding performance. Precise Biometrics is also the only biometric supplier who passed with 3 different card vendor submissions - a unique achievement in the industry.
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced its participation in the World Conference on Lung Cancer, to be held October 27-30, in Sydney, Australia.
› Verified 8 days ago
Others | 1 |
Total Volunteers | 1 |
---|
News Archive
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 2,500,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $500,000.00 to the Company.
Recently, several research groups emphasized how the pervasive screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may prove pivotal in determining infection seroprevalence in a given population defining previous exposure, screening health care workers, but also identifying highly reactive individuals that may act as donors for the therapeutic use of their convalescent serum.
A researcher in the United States has many of the pieces needed to cure a disease. Thousands of miles away, another scientist has uncovered some crucial information of his own - but thanks to the often secretive nature of research and development and the big-time dollars associated with major discoveries, they fail to connect.
As the results from the MINEX II report is released, Precise Biometrics emerges with the fastest standardized Match-on-Card and outstanding performance. Precise Biometrics is also the only biometric supplier who passed with 3 different card vendor submissions - a unique achievement in the industry.
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced its participation in the World Conference on Lung Cancer, to be held October 27-30, in Sydney, Australia.
› Verified 8 days ago
Active Hospice Care, Inc Location: 704 S Victory Blvd, Suite 100, Burbank, California, 91502 Phone: (818) 561-4410 |
Silverado Hospice Location: 601 S Glenoaks Blvd, Ste 201, Burbank, California, 91502 Phone: (818) 561-4410 |
Gerinet Healthcare Location: 2025 N Glenoaks Blvd, Suite 100, Burbank, California, 91504 Phone: (818) 561-4410 |
Burbank Hospice Care, Inc Location: 217 E Alameda Ave, Suite 205, Burbank, California, 91502 Phone: (818) 561-4410 |